⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
CJC/IPA is a dual-action peptide blend formulated for advanced research into growth hormone dynamics. By combining a long-acting GHRH analog with a selective ghrelin receptor agonist, this compound enables comprehensive study of endocrine signaling, recovery mechanisms, and anabolic pathways.
Product Specifications
Research Studies
Frequently Asked Questions
Related Products